HALO logo
halo search icon
GRF
Grifols, S.A. Class A

GRF · Grifols, S.A. Class A

9.03

EUR
0.00 (0.00%)
22/06/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro5.58B

PE

18.10

EV/EBITDA

10.4

DIV Yield

1.5%

Payout Ratio

0%

MQV Rating

4Weak

As at 22/06/2026 12:00:00 AM

Price Chart

Description

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO Consensus Value
  • HALO GARP
  • HALO Value

Key Fundamentals

EPS 3 yr Growth

92.40%

EBITDA Margin

22.40%

Operating Cashflow

€1,047m

Free Cash Flow Return

7.40%

ROIC

2.90%

Interest Coverage

2.70

Quick Ratio

0.90

Performance

52 weeks range

Low 8.43 - 13.7

Trade Value (12mth)

US$5,681,770.00

1 week

0%

1 month

-6.91%

YTD

-19.37%

1 year

-12.62%

All time high

34.31

Additional Data

Shares Outstanding (Fully Diluted)

681m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

11-Aug-25

Next Dividend Pay Date

13-Aug-25

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Very Strong

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Grifols, S.A. Class A (GRF:MCE)?
Halo FAQ
The current share price of Grifols, S.A. Class A (GRF:MCE) is EUR€9.03.
2
What is the 52-week high share price for Grifols, S.A. Class A (GRF:MCE)?
Halo FAQ
The 52-week high share price for Grifols, S.A. Class A (GRF:MCE) is EUR€13.70.
3
What is the 52-week low share price for Grifols, S.A. Class A (GRF:MCE)?
Halo FAQ
The 52-week low share price for Grifols, S.A. Class A (GRF:MCE) is EUR€8.43.
4
What is the dividend yield for Grifols, S.A. Class A (GRF:MCE)?
Halo FAQ
The current TTM dividend payout for Grifols, S.A. Class A (GRF:MCE) is 1.50.
5
What was Grifols, S.A. Class A (GRF:MCE) last dividend payment?
Halo FAQ
The last dividend payment of Grifols, S.A. Class A (GRF:MCE) is EUR€0.12.
6
What is the franking level for Grifols, S.A. Class A (GRF:MCE)?
Halo FAQ
Grifols, S.A. Class A (GRF:MCE) has a franking level of 0.00%.
7
In which sector is Grifols, S.A. Class A (GRF:MCE) classified?
Halo FAQ
Grifols, S.A. Class A (GRF:MCE) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Grifols, S.A. Class A (GRF:MCE)?
Halo FAQ
The current P/E ratio for Grifols, S.A. Class A (GRF:MCE) is 18.10.